Search
for
Sort by
Research 91–120 of 1000+
- Evaluating Carthamus Oxyacantha For 5α-Reductase Inhibition: Therapeutic Perspectives In BPH
- Health Risks Associated with Long-Term Finasteride and Dutasteride Use: It’s Time to Sound the Alarm
- Design, synthesis and biological evaluation of novel androst-3,5-diene-3-carboxylic acid derivatives as inhibitors of 5α-reductase type 1 and 2
- New 5?-reductase inhibitors: In vitro and in vivo effects
- 5-Alpha reductase deficiency
- Androgen antagonists in androgen target tissues
- Clinical use of 5α-reductase inhibitors
- 황금(黃芩)이 전립선비대증(前立腺肥大症) Rat에 미치는 영향
- The Role of Non-Aromatizable Testosterone Metabolite in Metabolic Pathways
- ORAL AND TOPICAL FINASTERIDE IN THE TREATMENT OF MALE ANDROGENETIC ALOPECIA – NARRATIVE REVIEW
- HPLC Profiling and Insilco studies of Chochurus olitoris (Jute) Leave Fractions against Steroid 5α-Reductase 2 (SRD5α2)
- Comparison of Clinical Efficacy of Finasteride and Dutasteride as 5-alpha Reductase Inhibitor
- Finasteride: a 5 alpha-reductase inhibitor.
- Design of Liposome Formulations for CRISPR/Cas9 Enzyme Immobilization: Evaluation of 5-Alpha-Reductase Enzyme Knockout for Androgenic Disorders
- Clinical Pearls in Men's Health
- New Drugs: Dutasteride
- HSD3B1 Genotypes Conferring Adrenal-Restrictive and Adrenal-Permissive Phenotypes in Prostate Cancer and Beyond
- The Effect of Finasteride on the Expression of Vascular Endothelial Growth Factor and Microvessel Density: A Possible Mechanism for Decreased Prostatic Bleeding in Treated Patients
- Current treatment of BPH
- 5-alpha reductase inhibitors use in prostatic disease and beyond
- Using 5 alpha reductase inhibitors safely: What primary care physicians need to know
- Every TURP Is not Just BPH
- Chapter 23. Therapeutic Control of Androgen Action
- Neuropsychological Assessment in Elderly Men with Benign Prostatic Hyperplasia Treated with Dutasteride
- Effect of the ethanol extract of Syzygium aromaticum (clove) leaves on the lipid profile and body weight in testosterone-induced benign prostatic hyperplasia rats
- Oral administration of berberine represses macrophage activation-associated benign prostatic hyperplasia: a pivotal involvement of the NF-κB
- Efectos de la terapia combinada del D-004 y el Finasteride sobre la hiperplasia de próstata inducida por testosterona en ratas
- Analysis of Data From Breast Diseases Treated With 5-Alpha Reductase Inhibitors for Benign Prostatic Hyperplasia
- Trends in the Development of New Drugs for Treatment of Benign Prostatic Hyperplasia
- The Benefits of Dual Inhibition of 5α Reductase